Ro CEO on the next phase of the Ozempic boom
Zach Reitano discusses scaling GLP-1 care, tackling backlash, and what comes after weight-loss drugs go mainstream. Since first appearing on the Masters of Scale podcast at the height of the Ozempic-Wegovy-Zepbound boom, Zach Reitano, CEO of Ro, has helped scale his company into a leading provider ...